Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy

Documenti analoghi

• Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
  di: Ardiani, Andressa, et al.
  Pubblicazione: (2014)
• Androgen deprivation therapy increases the sensitivity of human prostate carcinoma cells to T cell-mediated lysis through an androgen receptor dependent mechanism
  di: Gameiro, Sofia, et al.
  Pubblicazione: (2014)
• Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens
  di: Gameiro, Sofia R, et al.
  Pubblicazione: (2014)
• Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin
  di: Kwilas, Anna R., et al.
  Pubblicazione: (2016)
• Androgen deprivation and immunotherapy for the treatment of prostate cancer
  di: Gamat, Melissa, et al.
  Pubblicazione: (2017)